Drug Information Association Logo

Introduction to Portfolio Management and Performance Metrics

« Back to Listing


This highly interactive course will teach participants how to identify and consider the implications of managing performance metrics in their companies. It will provide case studies, simulation exercises, shared experiences, and lessons learned from others who have worked with performance metrics in their organizations. Tools and reference lists will be provided.

Course Level: Beginner 


What You Will Learn 

  • How to develop viable portfolio and pharmaceutical value processes
  • How to develop and use performance metrics for pharmaceutical development projects and for portfolios of development projects
  • Why performance metrics are needed and their value at the project and portfolio levels
  • How performance metrics contribute to improved business processes
  • Metrics available for measuring project and portfolio performance
  • Steps and challenges involved in the various stages of conducting and managing metrics
  • How project-level goal-setting integrates into the portfolio metrics process to enable good decision making

Who Should Attend 

  • Project managers
  • New portfolio managers and performance managers
  • Project team leaders
  • Project support office managers and staff
  • Operational leads

Learning Objectives 

Participants who complete this training should be able to:

  • Define how corporate strategy is delivered through the portfolio of new and lifecycle drug projects; and correlate corporate strategy to portfolio and project strategies
  • Discuss in general terms some performance metrics that might be valuable to measure for either projects or a portfolio of projects
  • Explain the importance of managing the process of conducting metrics, communicating and implementing recommendations resulting from metrics information
  • Support portfolio, strategy, and metrics/measurement processes effectively with sufficient knowledge to contribute to ongoing process improvement initiatives for these three processes

Contact Information 

Jessica McGrory at +1-215-442-6182 or Jessica.McGrory@diahome.org

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

« Back to Listing Back To Top